Brief: Centogene Joins Forces With Insilico Medicine For Niemann-Pick Disease Type C Target Discovery

Crown LiquidationCo NV in liquidatie

20/01/2022 12:35

Jan 20 (Reuters) - Centogene NV  39K.MU :
    * CENTOGENE JOINS FORCES WITH INSILICO MEDICINE FOR NIEMANN-PICK DISEASE
TYPE C
(NPC) TARGET DISCOVERY, APPLYING ARTIFICIAL INTELLIGENCE (AI) TO ACCELERATE
ORPHAN DRUG DEVELOPMENT
    * CENTOGENE NV - DURATION OF RESEARCH COLLABORATION WILL INITIALLY LAST 20
WEEKS

Source text for Eikon:  ID:nGNX9G8Zbm 
Further company coverage:  39K.MU 

 ((Kannaki.Deka@thomsonreuters.com;))